Press Releases
 
Cancer Immunotherapy Market Will hit at a CAGR of 14.6% from 2016 to 2024

, 13 February 2018 -- Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Owing to the presence of a pool of small and large players, the global cancer immunotherapy makes for a fragmented competitive landscape, although Roche Holding AG has managed to stay ahead of the curve in the recent past, according to a business intelligence report by Transparency Market Research (TMR). The report, developed as a reliable decision making tool for stockholders such as drug manufacturers and suppliers as well as research and development companies, has attributed the recent approvals of monoclonal antibody drugs such as Rituxan and Avastin for the flagship position of Roche Holding AG. Some of the other notable players identified by the report in the global cancer immunotherapy market are Bristol-Myers Squibb, Merck, and Novartis, primarily making a mark in immune checkpoint inhibitors and monoclonal antibodies.

Over the course of the forecast period of 2016 to 2024, the analysts of the report have projected the demand in the global cancer immunotherapy market to swell at an impressive CAGR of 14.6%, constituting an opportunity worth of US$124.88 bn by 2024, substantially more than evaluated worth of US$37.50 bn in 2015. Going forward, the report has expected a high level of threat to come from new entrants, which would be a result of incentives offered by various governments as well as foreign investments, owing to the widespread demand. In the near future, the leading companies are also expected to focus on acquisitions and partnerships as well as aspire for patent protection. Pfizer, AstraZeneca, Amgen, Bayer AG, Janssen Global Services, LLC, and Eli Lilly and Company are some of the other notable players operating in this market.

Based on therapy type, the TMR report has segmented the global cancer immunotherapy market into immune checkpoint inhibitors, monoclonal antibodies, CTLA-4, PD-1/PD-L1, cancer vaccines, immune system modulators, and others, with the monoclonal antibodies segment providing for the maximum demand, although immune checkpoint inhibitors are projected for a better growth rate.



Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4312

Based on therapeutic area, the market has been bifurcated into breast cancer, lung cancer, prostate cancer, melanoma, colorectal cancer, blood cancer, and others, whereas end user classification of the market has been done into ambulatory surgical centers (ASCs), hospitals, specialty clinics, and cancer research centers. Geographically, North America and Europe have been identified as most profitable regions, although vastly populated emerging economies of India and China are expected to increment focus on Asia Pacific by the leading vendors.

Strong Prevalence of Cancer Driving Demand

Prevalence of cancer, growing adoption of immunotherapy over traditional and conventional therapeutics, development of bioinformatics tools that offer enhanced drug development options, increasing demand for cancer monoclonal antibodies, vast profile of promising pipeline, and growing popularity of patient assistance programs are a few prominent factors expected to drive the global cancer immunotherapy market in the near future. For instance, The FDA has approveds Keytruda (Pembrolizumab) and Opdivo (Niolumab) for sale in the U.S.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4312

On the other hand, poor infrastructure of diagnosis and screen in a number of emerging economies, patent expiry of some of the leading drugs in the segment, extremely high cost of development of novel drugs, risk of side effects, and strict regulations from various governments before the drug is granted approval are some of the challenges obstructing the prosperity of the global cancer immunotherapy market.

Nevertheless, the vendors operating in this market stand to gain new opportunities from growing awareness regarding the prevalence of cancer among urban population as a result of radical penetration of social media in the past decade, strategic alliances by the vendors to expand geographically, emergence of biosimilars as well as targeted and combination therapies.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4312

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com

# # #


Submitted by Sandy Researcher, Transparency Market Research on Tuesday, 13 February 2018 at 6:18 PM
Category: Health Care & Medical
 
Related News

Immunoassay Instruments Market to Reach US$23.3 bn by 2020
Monday, 21 May 2018

Continuous Glucose Monitoring Market to Grow at a CAGR of 13.60% through 2019
Monday, 21 May 2018

Medical Fiber Optics Market CAGR Projected to Grow at 7.60% through 2019
Monday, 21 May 2018

Surgical Navigation Systems Market to Reach US$295.5 Mn by 2020
Monday, 21 May 2018

Cell Culture Protein Surface Coatings Market will Exhibit a Steady 13.60% CAGR through 2020
Monday, 21 May 2018

Related Events

2018 Off-Label Regulatory Compliance Congress
Monday, 21 May 2018

4th European Clinical Trials Inspection Readiness
Monday, 21 May 2018

Medicaid Managed Care Congress
Monday, 21 May 2018

Drug Delivery Design & Partnering - May 21-22, 2018 - San Francisco, CA
Monday, 21 May 2018

Product Recalls Forum
Monday, 21 May 2018

Latest News

The ‘Shen Yun’ show provokes controversy
Tuesday, 22 May 2018

Mostofi Yachts Unveils New Yacht
Tuesday, 22 May 2018

How to select the Best crypto exchange service?
Monday, 21 May 2018

What are the benefits of using iCoin?
Monday, 21 May 2018

Ready to Assemble Furniture Market Outlook: Ken Research
Monday, 21 May 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 22 May 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Argus Latin America LNG Summit
  • Argus North American Natural Gas Markets
  • Drug Delivery Design & Partnering - May 21-22, 2018 - San Francisco, CA
  • 4th European Clinical Trials Inspection Readiness
  • 2018 Off-Label Regulatory Compliance Congress

  • Latest Jobs
    Sorry, there are currently no entries posted here.